These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 17046829)
1. Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation. Li W; Marshall C; Mei L; Gelfand J; Seykora JT J Biol Chem; 2007 Jan; 282(2):1161-9. PubMed ID: 17046829 [TBL] [Abstract][Full Text] [Related]
2. Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53. Zhao L; Li W; Marshall C; Griffin T; Hanson M; Hick R; Dentchev T; Williams E; Werth A; Miller C; Bashir H; Pear W; Seykora JT Cancer Res; 2009 Dec; 69(24):9439-47. PubMed ID: 19934324 [TBL] [Abstract][Full Text] [Related]
3. 'Srcasm: a novel Src activating and signaling molecule. Seykora JT; Mei L; Dotto GP; Stein PL J Biol Chem; 2002 Jan; 277(4):2812-22. PubMed ID: 11711534 [TBL] [Abstract][Full Text] [Related]
4. Srcasm modulates EGF and Src-kinase signaling in keratinocytes. Li W; Marshall C; Mei L; Dzubow L; Schmults C; Dans M; Seykora J J Biol Chem; 2005 Feb; 280(7):6036-46. PubMed ID: 15579470 [TBL] [Abstract][Full Text] [Related]
5. Srcasm overexpression in psoriasis-insights into pathogenesis. Pulitzer M; Li W; Hanson M; Singh F; Elenitsas R; Gelfand JM; VanVoorhees A; Seykora JT J Cutan Pathol; 2007 Feb; 34(2):160-5. PubMed ID: 17244028 [TBL] [Abstract][Full Text] [Related]
6. Epidermal hyperplasia induced by Raf-MAPK signaling requires Stat3 activation. Tarutani M; Nakajima K; Takaishi M; Ohko K; Sano S J Dermatol Sci; 2013 Nov; 72(2):110-5. PubMed ID: 23870655 [TBL] [Abstract][Full Text] [Related]
7. Defective thymocyte maturation by transgenic expression of a truncated form of the T lymphocyte adapter molecule and Fyn substrate, Sin. Donlin LT; Roman CA; Adlam M; Regelmann AG; Alexandropoulos K J Immunol; 2002 Dec; 169(12):6900-9. PubMed ID: 12471123 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of Src-family tyrosine kinases by Srcasm and c-Cbl: A comparative analysis. Lee V; Griffin TD; Suzuki-Horiuchi Y; Wushanley L; Kweon Y; Marshall C; Li W; Ayli E; Haimovic A; Hines A; Seykora JT J Carcinog; 2021; 20():21. PubMed ID: 34729053 [TBL] [Abstract][Full Text] [Related]
10. Src family kinases are required for integrin but not PDGFR signal transduction. Klinghoffer RA; Sachsenmaier C; Cooper JA; Soriano P EMBO J; 1999 May; 18(9):2459-71. PubMed ID: 10228160 [TBL] [Abstract][Full Text] [Related]
11. Src family kinases Fyn and Lyn are constitutively activated and mediate plasmacytoid dendritic cell responses. Dallari S; Macal M; Loureiro ME; Jo Y; Swanson L; Hesser C; Ghosh P; Zuniga EI Nat Commun; 2017 Apr; 8():14830. PubMed ID: 28368000 [TBL] [Abstract][Full Text] [Related]
12. Activation of c-Src and Fyn kinases by protein-tyrosine phosphatase RPTPalpha is substrate-specific and compatible with lipid raft localization. Vacaresse N; Møller B; Danielsen EM; Okada M; Sap J J Biol Chem; 2008 Dec; 283(51):35815-24. PubMed ID: 18948260 [TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529. Kang S; Dong S; Guo A; Ruan H; Lonial S; Khoury HJ; Gu TL; Chen J J Biol Chem; 2008 Feb; 283(8):4652-7. PubMed ID: 18156174 [TBL] [Abstract][Full Text] [Related]
14. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells. Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875 [TBL] [Abstract][Full Text] [Related]
15. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072 [TBL] [Abstract][Full Text] [Related]
16. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Lu KV; Zhu S; Cvrljevic A; Huang TT; Sarkaria S; Ahkavan D; Dang J; Dinca EB; Plaisier SB; Oderberg I; Lee Y; Chen Z; Caldwell JS; Xie Y; Loo JA; Seligson D; Chakravari A; Lee FY; Weinmann R; Cloughesy TF; Nelson SF; Bergers G; Graeber T; Furnari FB; James CD; Cavenee WK; Johns TG; Mischel PS Cancer Res; 2009 Sep; 69(17):6889-98. PubMed ID: 19690143 [TBL] [Abstract][Full Text] [Related]
17. Fyn deficiency attenuates renal fibrosis by inhibition of phospho-STAT3. Seo HY; Jeon JH; Jung YA; Jung GS; Lee EJ; Choi YK; Park KG; Choe MS; Jang BK; Kim MK; Lee IK Kidney Int; 2016 Dec; 90(6):1285-1297. PubMed ID: 27616741 [TBL] [Abstract][Full Text] [Related]
18. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. Mason LH; Willette-Brown J; Taylor LS; McVicar DW J Immunol; 2006 Jun; 176(11):6615-23. PubMed ID: 16709819 [TBL] [Abstract][Full Text] [Related]
19. Src family kinase-independent signal transduction and gene induction by leukemia inhibitory factor. Laszlo GS; Nathanson NM J Biol Chem; 2003 Jul; 278(30):27750-7. PubMed ID: 12764151 [TBL] [Abstract][Full Text] [Related]
20. The focal adhesion kinase Pyk2 links Ca2+ signalling to Src family kinase activation and protein tyrosine phosphorylation in thrombin-stimulated platelets. Canobbio I; Cipolla L; Guidetti GF; Manganaro D; Visconte C; Kim S; Okigaki M; Falasca M; Kunapuli SP; Torti M Biochem J; 2015 Jul; 469(2):199-210. PubMed ID: 25967238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]